Early Phase Biologic Development: Upstream and Downstream Processes Considerations

Event link to be sent with confirmation

Event Details:

Biopharmaceutical products in development continue to increase in complexity, which effects how companies choose to express proteins and eventually, manufacture at clinical and commercial scale.

In this webinar, co-organized with Medicon Valley Alliance, experts from Catalent Biologics and Sartorius will discuss new cell line development methodologies, including new instrumentation, which are enabling complex programs to be performed more efficiently, as well as ways that perfusion tools are used to implement upstream process intensification for clinical and commercial programs. 

By submitting this form you understand and accept that Catalent tracks your website activities to be able to offer you a more tailored response or information to meet your requirements, and that your personal data will be held in accordance with our Privacy Policy | Privacy Shield Statement.